Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Here comes ICD-10

This article was originally published in The Gray Sheet

Executive Summary

CMS issues a proposed regulation Aug. 15 to adopt ICD-10 diagnosis and procedure codes effective Oct. 1, 2011. The code set would replace 30-year-old ICD-9, used by health care providers, payers and other stakeholders for billing, tracking and other purposes. Device groups have long urged an "expeditious" switch to ICD-10, which is already used in most other countries and offers more than 155,000 codes to ICD-9's 17,000, in order to better incorporate new technologies (1"The Gray Sheet" July 31, 2006, p. 18). Payers have asked for more time to make the switch, but CMS Acting Administrator Kerry Weems told stakeholders last October to begin making transition plans. Comments on the proposed regulation are due Oct. 21

You may also be interested in...



House Passes Health IT Bill; 2010 Date Set For ICD-10 Adoption

The "Health Information Technology Promotion Act" (HR 4157), including a 2010 adoption date for the next-generation ICD-10 Medicare coding system, passed in the House July 27 by a vote of 270-148

Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation

Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026464

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel